The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial.

[1]  I. Tannock,et al.  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) chemotherapy for transitional cell carcinoma: the Princess Margaret Hospital experience. , 1989, The Journal of urology.

[2]  H. Scher.  Should single agents be standard therapy for urothelial tract tumors? , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  R. Kefford,et al.  A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tract. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  R. Babaian,et al.  Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  N. Geller,et al.  M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium. , 1988, The Journal of urology.

[6]  M. Troner,et al.  Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial. , 1987, The Journal of urology.

[7]  P. Elson,et al.  Comparative activity and toxicity of cis-diamminedichloroplatinum (DDP) and a combination of doxorubicin, cyclophosphamide, and DDP in disseminated transitional cell carcinomas of the urinary tract. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  N. Geller,et al.  Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium. , 1985, The Journal of urology.

[9]  M. Soloway,et al.  A comparison of cisplatin and the combination of cisplatin and cyclophosphamide in advanced urothelial cancer. A national bladder cancer collaborative group a study , 1983, Cancer.

[10]  I. Tannock,et al.  Chemotherapy for metastatic transitional carcinoma of the urinary tract: A prospective trial of methotrexate, adriamycin, and cyclophosphamide (MAC) with cis‐platinum for failure , 1983, Cancer.

[11]  Skinner Dg.  Technique of radical cystectomy. , 1981 .

[12]  D. Johnson,et al.  Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report. , 1977, JAMA.

[13]  D. Skinner,et al.  Current state of classification and staging of bladder cancer. , 1977, Cancer research.

[14]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[15]  P. Armitage,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. , 1976, British Journal of Cancer.

[16]  D R Taves,et al.  Minimization: A new method of assigning patients to treatment and control groups , 1974, Clinical pharmacology and therapeutics.

[17]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .